Moving averages
SMA 200$184.41-11.90%
Company profile
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$243.86B
P/E ratio23.75
EPS$6.62
Beta0.211
Dividend yield2.04%
52-week high$209.11
52-week low$143.33
Similar stocks in Drug Manufacturers - General
RSI alerts for AZN
Get an email the moment AstraZeneca PLC crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 15 August 2026 at 6:23 AM EDT